Drugs and Human Performance Fact Sheets [2014]

NHTSA - Behavioral Safety Researchhttps://doi.org/10.21949/15258212014PDFTech ReportCouper, Fiona J.Logan, Barry K.Washington State Patrol. Forensic Laboratory Services BureauUnited States. National Highway Traffic Safety AdministrationWashington State Patrol. Forensic Laboratory Services BureauWashingtonImpaired driversDrug usePerformance evaluationsPsychologyLaw enforcementEvaluationMedicationDrug abuseDOT HS 809 725A panel of international experts on drug-impaired driving met in Seattle during August 2000 to review developments in the field of drugs and human performance over the last 10 years; to identify the specific effects that both illicit and prescription drugs have on driving; and to develop guidance for others when dealing with drug-impaired driving problems. Delegates represented the fields of psychopharmacology, behavioral psychology, drug chemistry, forensic toxicology, medicine, and law enforcement experts trained in the recognition of drug effects on drivers in the field.These Fact Sheets represent the conclusions of the Panel and include the state of current scientific knowledge in the area of drugs and human performance for the 16 drugs selected for evaluation. The selected drugs include over-the-counter medications such as dextromethorphan and diphenhydramine; prescription medications such as carisoprodol, diazepam and zolpidem; and abused and/or illegal drugs such as cocaine, GHB, ketamine, LSD, marijuana, methadone, methamphetamine, MDMA, morphine, PCP and toluene.Keyword continuation: illicit and licit drugs and traffic safety, drugs and driving, drug-impaired driving.129